SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy
Aldostefano Porcari(University of Trieste), Marianna Fontana(The Royal Free Hospital), Aviva Petrie(Eastman Dental Hospital), Alberto Cipriani(Azienda Ospedale - Università Padova), Simone Longhi(Azienda USL di Bologna), Beatrice Musumeci(Sapienza University of Rome), Michele Emdin(Scuola Superiore Sant'Anna), Gianfranco Sinagra(University of Trieste), Philip N. Hawkins(The Royal Free Hospital), Cristina Chimenti(Policlinico Umberto I), Valentina Allegro(University of Trieste), Christian Nitsche(Medical University of Vienna), Mattia Zampieri(Azienda Ospedaliero-Universitaria Careggi), Rishi Patel(MACOM (United States)), Marco Metra(GoHypersonic (United States)), Scott D. Solomon(Brigham and Women's Hospital), Adam Ioannou(MACOM (United States)), Marcus A. Urey(University of California San Diego), Daniela Tomasoni(University of Brescia), Carol Whelan(Boston University), Giulio Sinigiani(University of Padua), Ahmad Masri(Oregon Health & Science University), Yousuf Razvi(MACOM (United States)), Marco Canepa(Ospedale Policlinico San Martino), Muhammad U. Rauf(MACOM (United States)), Marco Merlo(Ospedale Policlinico San Martino), Christina Kronberger(Medical University of Vienna), Francesco Cappelli(Fondazione Toscana Gabriele Monasterio), R Badr-Eslam(Medical University of Vienna), Luca Bordignon(University of Trieste), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Matteo Serenelli(University of Ferrara)
Cited by 137
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2022|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k